ATE537142T1 - Übergangsmetallkatalysierte synthese von n- aminoindolen - Google Patents

Übergangsmetallkatalysierte synthese von n- aminoindolen

Info

Publication number
ATE537142T1
ATE537142T1 AT08734883T AT08734883T ATE537142T1 AT E537142 T1 ATE537142 T1 AT E537142T1 AT 08734883 T AT08734883 T AT 08734883T AT 08734883 T AT08734883 T AT 08734883T AT E537142 T1 ATE537142 T1 AT E537142T1
Authority
AT
Austria
Prior art keywords
transition metal
metal catalyzed
aminoindoles
formula
catalyzed synthesis
Prior art date
Application number
AT08734883T
Other languages
German (de)
English (en)
Inventor
Nis Halland
M Nazare
Andreas Lindenschmidt
Omar Rkyek
Matthias Urmann
Jorge Alonso
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Application granted granted Critical
Publication of ATE537142T1 publication Critical patent/ATE537142T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT08734883T 2007-04-13 2008-03-29 Übergangsmetallkatalysierte synthese von n- aminoindolen ATE537142T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07007585 2007-04-13
PCT/EP2008/002519 WO2008125207A1 (en) 2007-04-13 2008-03-29 A transition metal catalyzed synthesis of n-aminoindoles

Publications (1)

Publication Number Publication Date
ATE537142T1 true ATE537142T1 (de) 2011-12-15

Family

ID=38457866

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08734883T ATE537142T1 (de) 2007-04-13 2008-03-29 Übergangsmetallkatalysierte synthese von n- aminoindolen

Country Status (12)

Country Link
US (1) US8026375B2 (https=)
EP (1) EP2134682B1 (https=)
JP (1) JP5412422B2 (https=)
KR (1) KR20100015546A (https=)
CN (1) CN101657422A (https=)
AT (1) ATE537142T1 (https=)
AU (1) AU2008238379A1 (https=)
BR (1) BRPI0810199A2 (https=)
CA (1) CA2683578A1 (https=)
IL (1) IL201253A0 (https=)
MX (1) MX2009010536A (https=)
WO (1) WO2008125207A1 (https=)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1831225A2 (en) 2004-11-19 2007-09-12 The Regents of the University of California Anti-inflammatory pyrazolopyrimidines
WO2007114926A2 (en) 2006-04-04 2007-10-11 The Regents Of The University Of California Kinase antagonists
GB2467670B (en) 2007-10-04 2012-08-01 Intellikine Inc Chemical entities and therapeutic uses thereof
US8193182B2 (en) 2008-01-04 2012-06-05 Intellikine, Inc. Substituted isoquinolin-1(2H)-ones, and methods of use thereof
MX2010007419A (es) 2008-01-04 2010-11-12 Intellikine Inc Ciertas entidades quimicas, composiciones y metodos.
US8993580B2 (en) 2008-03-14 2015-03-31 Intellikine Llc Benzothiazole kinase inhibitors and methods of use
EP2252293B1 (en) 2008-03-14 2018-06-27 Intellikine, LLC Kinase inhibitors and methods of use
US20110224223A1 (en) 2008-07-08 2011-09-15 The Regents Of The University Of California, A California Corporation MTOR Modulators and Uses Thereof
BRPI0915231A2 (pt) 2008-07-08 2018-06-12 Intellikine Inc compostos inibidores de quinase e métodos de uso
CA2738429C (en) 2008-09-26 2016-10-25 Intellikine, Inc. Heterocyclic kinase inhibitors
EP2358720B1 (en) 2008-10-16 2016-03-02 The Regents of The University of California Fused ring heteroaryl kinase inhibitors
US8476431B2 (en) 2008-11-03 2013-07-02 Itellikine LLC Benzoxazole kinase inhibitors and methods of use
JP5789252B2 (ja) 2009-05-07 2015-10-07 インテリカイン, エルエルシー 複素環式化合物およびその使用
WO2011047384A2 (en) 2009-10-16 2011-04-21 The Regents Of The University Of California Methods of inhibiting ire1
CA2799579A1 (en) 2010-05-21 2011-11-24 Intellikine, Inc. Chemical compounds, compositions and methods for kinase modulation
JP2013545749A (ja) 2010-11-10 2013-12-26 インフィニティー ファーマシューティカルズ, インコーポレイテッド 複素環化合物及びその使用
ES2637113T3 (es) 2011-01-10 2017-10-10 Infinity Pharmaceuticals, Inc. Procedimientos para preparar isoquinolinonas y formas sólidas de isoquinolinonas
CN102093334B (zh) * 2011-02-22 2013-05-08 郑州大学 一组稠环噻吩类化合物的合成方法
US9295673B2 (en) 2011-02-23 2016-03-29 Intellikine Llc Combination of mTOR inhibitors and P13-kinase inhibitors, and uses thereof
HK1198443A1 (en) 2011-07-19 2015-04-24 无限药品股份有限公司 Heterocyclic compounds and uses thereof
AR088218A1 (es) 2011-07-19 2014-05-21 Infinity Pharmaceuticals Inc Compuestos heterociclicos utiles como inhibidores de pi3k
MX2014002542A (es) 2011-08-29 2014-07-09 Infinity Pharmaceuticals Inc Compuestos heterociclicos y usos de los mismos.
CA2846496C (en) 2011-09-02 2020-07-14 The Regents Of The University Of California Substituted pyrazolo[3,4-d]pyrimidines and uses thereof
US8940742B2 (en) 2012-04-10 2015-01-27 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
US8828998B2 (en) 2012-06-25 2014-09-09 Infinity Pharmaceuticals, Inc. Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
JP2015532287A (ja) 2012-09-26 2015-11-09 ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア Ire1の調節
AU2013337717B2 (en) 2012-11-01 2018-10-25 Infinity Pharmaceuticals, Inc. Treatment of cancers using PI3 kinase isoform modulators
US9481667B2 (en) 2013-03-15 2016-11-01 Infinity Pharmaceuticals, Inc. Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
PT3052485T (pt) 2013-10-04 2021-10-22 Infinity Pharmaceuticals Inc Compostos heterocíclicos e suas utilizações
US9751888B2 (en) 2013-10-04 2017-09-05 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
CN103755621B (zh) * 2014-01-23 2015-08-05 清华大学 由芳基肼和炔烃制备多取代吲哚的方法
MX382033B (es) 2014-03-19 2025-03-13 Infinity Pharmaceuticals Inc Compuestos heterocíclicos para utilizarlos en el tratamiento de trastornos mediados por pi3k-gamma.
WO2015160975A2 (en) 2014-04-16 2015-10-22 Infinity Pharmaceuticals, Inc. Combination therapies
WO2016054491A1 (en) 2014-10-03 2016-04-07 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
WO2016069796A1 (en) * 2014-10-28 2016-05-06 Spectrum Spine Ip Holdings, Llc Expandable, adjustable inter-body fusion devices and methods
WO2017048702A1 (en) 2015-09-14 2017-03-23 Infinity Pharmaceuticals, Inc. Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same
WO2017161116A1 (en) 2016-03-17 2017-09-21 Infinity Pharmaceuticals, Inc. Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
WO2017214269A1 (en) 2016-06-08 2017-12-14 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
SG11201811237WA (en) 2016-06-24 2019-01-30 Infinity Pharmaceuticals Inc Combination therapies
KR102038977B1 (ko) * 2016-12-30 2019-11-01 사빅 에스케이 넥슬렌 컴퍼니 피티이 엘티디 신규한 시클로펜타[b]티오펜일 전이금속 화합물, 이를 포함하는 전이금속 촉매 조성물, 및 이를 이용한 에틸렌 단독중합체 또는 에틸렌과 α-올레핀의 공중합체의 제조방법
WO2020132384A1 (en) 2018-12-21 2020-06-25 Celgene Corporation Thienopyridine inhibitors of ripk2
EP3898725B1 (en) * 2018-12-21 2025-10-01 Dow Global Technologies LLC Heterocycle-heterocycle-based group iv transition metal catalysts for olefin polymerization
CN116813522A (zh) * 2023-05-04 2023-09-29 广州方中化工有限公司 一种含吲哚的苯磺酰脲类化合物的制备方法与应用
CN118638038B (zh) * 2024-06-05 2024-12-03 常州大学 一种n-n轴手性吲哚酰胺类化合物及其合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0287982B1 (en) * 1987-04-24 1994-12-07 Hoechst-Roussel Pharmaceuticals Incorporated N-(Pyridinyl)-1H-indol-1-amines, a process for their preparation and their use as medicaments
US4983608A (en) 1989-09-05 1991-01-08 Hoechst-Roussell Pharmaceuticals, Inc. N-substituted-4-pyrimidinamines and pyrimidinediamines
EP1035114B1 (en) 1999-03-10 2004-11-24 Tosoh Corporation Processes for the preparation of nitrogen-heterocyclic compounds
FR2842196B1 (fr) * 2002-07-15 2006-01-13 Rhodia Polyamide Intermediates Procede de fabrication de composes nitriles a partir de composes a insaturation ethylenique
EP2119455A1 (en) 2004-04-08 2009-11-18 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Tripartite raftophilic structures and their use

Also Published As

Publication number Publication date
WO2008125207A1 (en) 2008-10-23
AU2008238379A1 (en) 2008-10-23
CA2683578A1 (en) 2008-10-23
US8026375B2 (en) 2011-09-27
KR20100015546A (ko) 2010-02-12
EP2134682A1 (en) 2009-12-23
IL201253A0 (en) 2010-05-31
CN101657422A (zh) 2010-02-24
US20100168429A1 (en) 2010-07-01
JP5412422B2 (ja) 2014-02-12
MX2009010536A (es) 2009-10-22
EP2134682B1 (en) 2011-12-14
JP2010523605A (ja) 2010-07-15
BRPI0810199A2 (pt) 2014-10-14

Similar Documents

Publication Publication Date Title
ATE537142T1 (de) Übergangsmetallkatalysierte synthese von n- aminoindolen
MX2009013753A (es) Una sintesis regioselectiva catalizada por cobre de bencimidazoles y azabencimidazoles.
MX2009014203A (es) Una sintesis de 2h-indazoles catalizada por un metal de transicion.
ATE544757T1 (de) Regioselektive, palladiumkatalysierte synthese von benzimidazolen und azabenzimidazolen
MY150379A (en) Fused heterocyclic derivative and use thereof
TW200617009A (en) Organic compounds
BRPI0813273A2 (pt) Síntese catalisada por metal regiosseletivo de benzimidazóis e azabenzimidazóis anelados
TNSN08372A1 (en) Heterocyclic amides for use as pharmaceuticals
TW200732335A (en) Organic compounds
DE602008002843D1 (de) Neue antimikrobielle verbindungen, ihre synthese und ihre verwendung zur behandlung von säugetierinfektionen
MX2009007713A (es) Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas.
TW200635921A (en) Organic compounds
MX2009013738A (es) Un procedimiento catalizado por paladio para el acoplamiento de alquinos terminales con tosilatos de arilo.
SE0400850D0 (sv) Novel Compounds
GB0508318D0 (en) Organic compounds
TW200732337A (en) Organic compounds
DE602006009789D1 (de) Acetylenderivate
WO2008156102A1 (ja) ピラゾロン誘導体及びそれらを有効成分とするpde阻害剤
TW200744996A (en) Improved process for the production of nitroisourea derivative
MY151461A (en) A process for the palladium-catalyzed coupling of terminal alkynes with heteroayl tosylates and heteroaryl benzenesulfonates
TW200716521A (en) Substituted aryl oximes
FR2977253B1 (fr) Reactif organostannique alcoxyle supporte, preparation et utilisation pour la synthese de tetrazoles en phase heterogene
MX2007007554A (es) Oxiarenos sustituidos.
TW200621693A (en) Ortho-substituted pentafluorosulfanylbenzenes, process for their preparation and their use as synthetic intermediates
TH92804A (https=)